Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Genethon
First Clinical Trial Results of Gene Therapy (GNT0004) for Duchenne Muscular Dystrophy Presented at International Myology 2024 Congress
April 23, 2024
From
Genethon
Via
Business Wire
Genethon Pursues Different Strategies for Ensuring Patient Access to Gene Therapies for Rare Diseases
February 29, 2024
From
Genethon
Via
Business Wire
Genethon Using Artificial Intelligence to Improve Effectiveness of Gene Therapies and Patient Access
November 27, 2023
From
Genethon
Via
Business Wire
Genethon Announces Publication in The Lancet Neurology of Clinical Trial Results of a Gene Therapy for Myotubular Myopathy, a Severe Muscle Disease
November 17, 2023
From
Genethon
Via
Business Wire
Positive Phase 1/2 Clinical Trial Results of Genethon’s Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease, Published in The New England Journal of Medicine
August 22, 2023
From
Genethon
Via
Business Wire
GenoTher Biocluster Designation Bolsters French Leadership in Gene Therapy
July 10, 2023
From
Genethon
Via
Business Wire
Genethon Given PRIME Status by EMA for Gene Therapy To Treat Crigler-Najjar Syndrome, a Rare Liver Disease
March 07, 2023
From
Genethon
Via
Business Wire
Genethon Launches Pivotal Clinical Trial of Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease
January 10, 2023
From
Genethon
Via
Business Wire
Gene Therapies Continue to Emerge as Effective Treatments for Rare Diseases, But Complex Challenges Remain
February 28, 2022
From
Genethon
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.